Copyright
©2010 Baishideng.
World J Gastrointest Oncol. Jun 15, 2010; 2(6): 251-258
Published online Jun 15, 2010. doi: 10.4251/wjgo.v2.i6.251
Published online Jun 15, 2010. doi: 10.4251/wjgo.v2.i6.251
Goblet cell carcinoid | Carcinoid | Adenocarcinoma | |
Clinical features | |||
Age | 5th-6th decade | 4th decade | 7th decade |
Carcinoid syndrome | No | Yes | No |
Primary symptoms | Acute appendicitis | Acute appendicitis | Mass |
Gross appearance | > 2 cm, ill defined thickening | < 2 cm | > 2 cm, well defined mass |
Microscopic appearance | |||
Morphology | Clusters of goblet or signet-ring cells separated by fibrosis/pools of mucin | Nests of small cells | Well-formed glands to sheets of poorly differentiated signet-ring cells |
Atypia | Minimal | Minimal | Marked |
Mitosis | Rare | Rare | Increased |
Vascular and perineural invasion | Present | Absent | Present |
Infiltrative margins | Present | Absent | Present |
Special stains | |||
Argyrophil | Positive | Positive | Usually negative |
Argentaffin | Negative | Positive | Negative |
Mucicarmine/PAS/PASD | Positive in goblet cells | Negative | Positive |
IHC | |||
CEA | + | - | + |
CDX2 | + | - | + |
CAM5.2 | + | - | + |
CK20 | ± | - | + |
CK7 | ± | - | - |
CK19 | + | - | - |
Neuroendocrine markers | ± | ± | - |
Math1 and HD5 | + | - | + |
p53, p16 | - | - | + |
Molecular pathology | |||
DPC4, Kras, β-catenin mutation and p53 over expression | - | - | + |
Subbuswamy et al[2] | APX |
RH in case of cecal involvement | |
Klein[3] | APX |
Haqqani et al[40] | RH if base of appendix or caecum is involved |
Warkel et al[4] | RH in case of spread beyond appendix, atypia, and mitotic count ≥ 2/10 hpf |
Chen et al[41] | APX alone unless there is cecal involvement |
Olsson et al[42] | RH in case of spread beyond appendix, atypia, and mitotic count ≥ 2/10 hpf |
Edmonds et al[33] | RH in all cases |
Bak et al[39] | RH in case of spread beyond appendix, atypia, and mitotic count ≥ 2/10 hpf |
Park et al[43] | RH in all cases |
Rutledge et al[44] | RH in all cases |
Butler et al[36] | RH for cecal involvement, BSO in females |
Ramnani et al[13] | < 2 cm in size, without serosal & lymphatic involvement-APX |
More advanced tumor-RH | |
Kanthan et al[30] | RH |
Li et al[31] | RH for N1, M1 or Mib1 > 3% |
Varisco et al[23] | RH in case of spread beyond appendix, atypia, and mitotic count ≥ 2/10 hpf |
Byrn et al[35] | No value of RH in non-metastatic cases |
Pham et al[22] | RH with attendant mesenteric nodal resection for (1) T3/T4 disease or nodal involvement; (2) direct cecal involvement; and (3) clinically positive mesenteric nodes |
Bilateral oophorectomy for post menopausal women | |
O’Donnell et al[20] | RH irrespective of stage |
Tang et al[17] | Group A T1, 2-no recommendations |
T3 or 4, group B/C, perforation, positive margin-RH with oophorectomy if possible. CT in stage III/IV | |
Stage IV/group C- debulking/oophorectomy/systemic/intraperitoneal CT |
- Citation: Roy P, Chetty R. Goblet cell carcinoid tumors of the appendix: An overview. World J Gastrointest Oncol 2010; 2(6): 251-258
- URL: https://www.wjgnet.com/1948-5204/full/v2/i6/251.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v2.i6.251